𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Vandetanib in patients with inoperable hepatocellular carcinoma: A phase II, randomized, double-blind, placebo-controlled study

✍ Scribed by Chiun Hsu; Tsai-Sheng Yang; Teh-Ia Huo; Ruey-Kuen Hsieh; Chih-Wei Yu; Wei-Shou Hwang; Tsai-Yuan Hsieh; Wen-Tsung Huang; Yee Chao; Robin Meng; Ann-Lii Cheng


Book ID
116652689
Publisher
Elsevier Science
Year
2012
Tongue
English
Weight
881 KB
Volume
56
Category
Article
ISSN
0168-8278

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


A phase II, randomized, double-blind, pl
✍ Wallace, Daniel J. ;Stohl, William ;Furie, Richard A. ;Lisse, Jeffrey R. ;McKay, πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 372 KB πŸ‘ 2 views

## Abstract ## Objective To assess the safety, tolerability, biologic activity, and efficacy of belimumab in combination with standard of care therapy (SOC) in patients with active systemic lupus erythematosus (SLE). ## Methods Patients with a Safety of Estrogens in Lupus Erythematosus: National